Inventaire - your friends and communities are your best library

RANKL/RANK-beyond bones

author

Josef Penninger

1964 -

published in: Journal of Molecular Medicine

date of publication: 2011-07

language: English

Cites articles 85

Date

Title

Authors

2010-05-11

New knowledge on critical osteoclast formation and activation pathways from study of rare genetic diseases of osteoclasts: focus on the RANK/RANKL axis

Derek Anthony Scott
2010-08-16

An antibody against RANKL for the treatment of osteoporosis, inflammatory and malignant bone diseases
2010-11-08

Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study

Denise A Yardley, Yasuhiro Fujiwara
2010-01-08

Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content

Pier Paolo Di Fiore, Daniela Tosoni, Stefano Confalonieri, Manuela Vecchi, Giuseppe Viale
2010-04-11

Control of mammary stem cell function by steroid hormone signalling

Geoffrey J. Lindeman, Julie M Sheridan, Bhupinder Pal, Jane Visvader
2010-06-01

Progesterone induces adult mammary stem cell expansion

Hartland W Jackson, Purna A Joshi, Alexander G Beristain, Christine Clarke, Paul Waterhouse, Rama Khokha, Marco A Di Grappa
2010-11-04

Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer

Heather J Lee, Manolis Pasparakis, Lukas Kenner, Josef M Penninger, Purna A Joshi, Georg Schett
2010-11-04

RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis

Eva Gonzalez-Suarez
2010-03-16

Fever

Tamas Bartfai, Bruno Conti
2009-08-20

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

Michael McClung, Ian Reid, Silvano Adami, Richard Eastell
2009-08-11

Denosumab in men receiving androgen-deprivation therapy for prostate cancer

Jiří Heráček, Fred Saad
2009-02-23

Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates.

Karim Fizazi, Xavier Mariette
2009-11-26

Central control of fever and female body temperature by RANKL/RANK

Christian Pifl, Michael Bader, Josef M Penninger, Sara S Kilic, Arndt von Haeseler, Steffen Klaere
2009-01-01

Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial
2008-07-01

Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations

Barbara Cassani, Michael J. Rogers, Anna Villa, Luigi D Notarangelo, Sara S Kilic
2008-04-01

Effects of denosumab on bone mineral density and bone turnover in postmenopausal women.

David Kendler
2008-04-26

Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial

Michael McClung
2008-08-25

Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer

Rowan T Chlebowski
2008-09-01

The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance.

Josef Penninger, Taishin Akiyama, Yusuke Shimo, Hiromi Yanai, Takeshi Nitta, Jun-Ichiro Inoue, Mitsuru Matsumoto
2008-09-01

The cytokine RANKL produced by positively selected thymocytes fosters medullary thymic epithelial cells that express autoimmune regulator.

Josef Penninger, Taishin Akiyama, Koichi Matsuo, Takeshi Nitta, Jun-Ichiro Inoue, Mitsuru Matsumoto, Izumi Ohigashi, Yoshifumi Yokota
2008-04

GATA-3 and the regulation of the mammary luminal cell fate

Zena Werb, Jung-whan Kim
2008-05-09

Central control of thermogenesis in mammals

Kazuhiro Nakamura
2008-07-01

The role of exercise and PGC1alpha in inflammation and chronic disease

Bruce Spiegelman
2008-07-24

Cancer-related inflammation

Alberto Mantovani, Fran Balkwill
2007-05-14

RANK signals from CD4(+)3(-) inducer cells regulate development of Aire-expressing epithelial cells in the thymic medulla

Josef M Penninger, Simona W Rossi, William E. Jenkinson, Graham Anderson, Hamish S. Scott
2007-07-15

Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL.

Anna Villa, Andrea Del Fattore, Michael J. Rogers, Anna Teti, Miep H Helfrich, Annalisa Frattini
2007-04

Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems
2007-04-05

Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin

Michael Karin
2007-12-01

Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMD

Michael McClung, Stanley B Cohen
2007-09-04

Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastases

Rossana Berardi
2006-12

Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells

Josef M Penninger, Karin Loser
2006-03-01

Regulation of cancer cell migration and bone metastasis by RANKL

Josef M Penninger, Martin Schreiber, S. Jeffrey Dixon, Young-Yun Kong

Article - wd:Q28308042

Welcome to Inventaire

the library of your friends and communities

learn more